New automated cloud-ready solutions to enable customers to dramatically accelerate software development and validation. The companies are teaming up to increase the impact of the open-source library, ...
The global viral vector development market size is poised for remarkable growth, with a projected valuation of US$ 730.7 Million by the end of 2023 and an anticipated expansion at a Compound Annual ...
Avid Bioservices has expanded its viral vector development and manufacturing facility with the addition of analytical and process development suites. Avid Bioservices, a biologics-focused contract ...
The second Vector-R rocket lifts off on a low-altitude test flight from a site in Camden County, Georgia, Aug. 3. Credit: Vector WASHINGTON — Vector, one of dozens of ventures developing small launch ...
The Viral Vector Development Market is set for impressive growth, with its valuation expected to rise from USD 730.7 million in 2023 to USD 4.1 billion by 2033, reflecting a robust CAGR of 18.7% over ...
NORCAT has announced the launch of Vector@NORCAT, a partnership designed to provide technical and strategic artificial intelligence (AI) training and talent resourcing to support the advancement of ...
On Oct. 10, 2023, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced the launch of the Viral Vectors NIIMBL-led program. The program will be focused on ...
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its nAAVigation™ Vector Platform (nAAVigation). Leveraging decades of Adeno ...
Joint Solution to Drive Adoption of "Shift-Left" Software Development Methodologies with the Integration of Synopsys' Electronics Digital Twin Capabilities and Vector's Software Factory SUNNYVALE, ...
Platform has the capability to reduce time from process development to GMP by 55 percent and deliver a drug product in fewer than 8 months nAAVigation platform will be launched at the Cell & Gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results